Forte Biosciences, Inc. (FBRX)

Forte Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	93.41	22.24	37.13	41.1	42.04	58.77
Short-Term Investments	-	36.12	-	-	-	-
Cash & Short-Term Investments	93.41	58.37	37.13	41.1	42.04	58.77
Cash Growth	470.89%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Other Current Assets	2	2.98	1.2	0.41	0.48	1.13
Total Current Assets	95.41	61.35	38.33	41.51	42.52	59.9
Net Property, Plant & Equipment	0.15	0.08	0.11	-	-	1.24
Other Long-Term Assets	1.53	0.14	0.54	0.49	0.79	-
Total Assets	97.09	61.56	38.98	42	43.31	61.24
Accounts Payable	5.49	4.88	1.42	1.15	0.95	1.24
Accrued Expenses	7.5	4.2	2.24	2.03	0.81	1.02
Total Current Liabilities	12.99	9.08	3.67	3.18	1.76	2.26
Total Liabilities	12.99	9.08	3.67	3.18	1.76	2.26
Total Common Shareholders' Equity	84.1	52.48	35.31	38.82	41.55	58.98
Shareholders' Equity	84.1	52.48	35.31	38.82	41.55	58.98
Total Liabilities & Equity	97.09	61.56	38.98	42	43.31	61.24
Net Cash (Debt)	93.41	58.37	37.13	41.1	42.04	58.77
Net Cash Growth	60.05%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Net Cash Per Share	7.94	20.02	29.40	59.11	75.25	199.64
Book Value	84.1	52.48	35.31	38.82	41.55	58.98
Book Value Per Share	7.15	18.00	27.96	55.83	74.36	200.37
Tangible Book Value	84.1	52.48	35.31	38.82	41.55	58.98
Tangible Book Value Per Share	7.15	18.00	27.96	55.83	74.36	200.37

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q